No Effect of Dose Adjustment to the CYP2D6 Genotype in Patients With Severe Mental Illness

Anne B. Koopmans, David J. Vinkers, Igmar T. Poulina, Petra J. A. Gelan, Ron H. N. van Schaik, Hans W. Hoek, Peter N. van Harten

Research output: Contribution to journalArticleAcademicpeer-review

Original languageEnglish
Article number349
Number of pages9
JournalFrontiers in Psychiatry
Volume9
DOIs
Publication statusPublished - 7 Aug 2018

Keywords

  • CYP2D6
  • severe mental illness (SMI)
  • guidelines
  • dose adjustment
  • genotyping
  • psychopharmacology
  • personalized medicine
  • CURACAO EXTRAPYRAMIDAL SYNDROMES
  • TARDIVE-DYSKINESIA
  • RATING-SCALE
  • PERSONALIZED MEDICINE
  • INDUCED AKATHISIA
  • SCHIZOPHRENIA
  • PHARMACOGENETICS
  • ANTIPSYCHOTICS
  • 2D6
  • POLYMORPHISMS

Cite this

Koopmans, Anne B. ; Vinkers, David J. ; Poulina, Igmar T. ; Gelan, Petra J. A. ; van Schaik, Ron H. N. ; Hoek, Hans W. ; van Harten, Peter N. / No Effect of Dose Adjustment to the CYP2D6 Genotype in Patients With Severe Mental Illness. In: Frontiers in Psychiatry. 2018 ; Vol. 9.
@article{e60db623dc154de5802117338c2a3f15,
title = "No Effect of Dose Adjustment to the CYP2D6 Genotype in Patients With Severe Mental Illness",
keywords = "CYP2D6, severe mental illness (SMI), guidelines, dose adjustment, genotyping, psychopharmacology, personalized medicine, CURACAO EXTRAPYRAMIDAL SYNDROMES, TARDIVE-DYSKINESIA, RATING-SCALE, PERSONALIZED MEDICINE, INDUCED AKATHISIA, SCHIZOPHRENIA, PHARMACOGENETICS, ANTIPSYCHOTICS, 2D6, POLYMORPHISMS",
author = "Koopmans, {Anne B.} and Vinkers, {David J.} and Poulina, {Igmar T.} and Gelan, {Petra J. A.} and {van Schaik}, {Ron H. N.} and Hoek, {Hans W.} and {van Harten}, {Peter N.}",
year = "2018",
month = "8",
day = "7",
doi = "10.3389/fpsyt.2018.00349",
language = "English",
volume = "9",
journal = "Frontiers in Psychiatry",
issn = "1664-0640",
publisher = "Frontiers Media S.A.",

}

No Effect of Dose Adjustment to the CYP2D6 Genotype in Patients With Severe Mental Illness. / Koopmans, Anne B.; Vinkers, David J.; Poulina, Igmar T.; Gelan, Petra J. A.; van Schaik, Ron H. N.; Hoek, Hans W.; van Harten, Peter N.

In: Frontiers in Psychiatry, Vol. 9, 349, 07.08.2018.

Research output: Contribution to journalArticleAcademicpeer-review

TY - JOUR

T1 - No Effect of Dose Adjustment to the CYP2D6 Genotype in Patients With Severe Mental Illness

AU - Koopmans, Anne B.

AU - Vinkers, David J.

AU - Poulina, Igmar T.

AU - Gelan, Petra J. A.

AU - van Schaik, Ron H. N.

AU - Hoek, Hans W.

AU - van Harten, Peter N.

PY - 2018/8/7

Y1 - 2018/8/7

KW - CYP2D6

KW - severe mental illness (SMI)

KW - guidelines

KW - dose adjustment

KW - genotyping

KW - psychopharmacology

KW - personalized medicine

KW - CURACAO EXTRAPYRAMIDAL SYNDROMES

KW - TARDIVE-DYSKINESIA

KW - RATING-SCALE

KW - PERSONALIZED MEDICINE

KW - INDUCED AKATHISIA

KW - SCHIZOPHRENIA

KW - PHARMACOGENETICS

KW - ANTIPSYCHOTICS

KW - 2D6

KW - POLYMORPHISMS

U2 - 10.3389/fpsyt.2018.00349

DO - 10.3389/fpsyt.2018.00349

M3 - Article

VL - 9

JO - Frontiers in Psychiatry

JF - Frontiers in Psychiatry

SN - 1664-0640

M1 - 349

ER -